vs
Ginkgo Bioworks Holdings, Inc.（DNA）与合众银行（WASH）财务数据对比。点击上方公司名可切换其他公司
合众银行的季度营收约是Ginkgo Bioworks Holdings, Inc.的1.7倍（$57.8M vs $33.4M），过去两年合众银行的营收复合增速更高（9.5% vs -6.2%）
Ginkgo Bioworks Holdings, Inc.是一家2008年由五名麻省理工学院科学家创立的美国生物技术企业，由杰森·凯利掌舵。公司专注于基因工程改造，为其他生物科技企业开发具备工业应用价值的菌株，帮助合作方省去合成生物学设计初期的重复研发成本，号称「生物制造平台企业」，2019年估值就已达42亿美元。
美国合众银行是一家美国跨国金融机构，总部位于明尼苏达州明尼阿波利斯，在特拉华州注册成立。截至2025年，该银行为美国第五大银行，也是美国中西部规模最大的银行，被金融稳定委员会认定为具有系统重要性的金融机构。它主营银行、投资、抵押贷款等多元金融业务。
DNA vs WASH — 直观对比
营收规模更大
WASH
是对方的1.7倍
$33.4M
两年增速更快
WASH
近两年复合增速
-6.2%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $33.4M | $57.8M |
| 净利润 | — | $12.6M |
| 毛利率 | — | — |
| 营业利润率 | -211.9% | — |
| 净利率 | — | 21.8% |
| 营收同比 | -23.8% | — |
| 净利润同比 | — | 3.5% |
| 每股收益（稀释后） | $-1.41 | $0.66 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DNAWASH
| Q1 26 | — | $57.8M | ||
| Q4 25 | $33.4M | $59.3M | ||
| Q3 25 | $38.8M | $56.5M | ||
| Q2 25 | $49.6M | $54.3M | ||
| Q1 25 | $48.3M | $59.1M | ||
| Q4 24 | $43.8M | $12.4M | ||
| Q3 24 | $89.0M | $48.5M | ||
| Q2 24 | $56.2M | $48.2M |
净利润DNAWASH
| Q1 26 | — | $12.6M | ||
| Q4 25 | — | $16.0M | ||
| Q3 25 | $-80.8M | $10.8M | ||
| Q2 25 | $-60.3M | $13.2M | ||
| Q1 25 | $-91.0M | $12.2M | ||
| Q4 24 | — | $-60.8M | ||
| Q3 24 | $-56.4M | $11.0M | ||
| Q2 24 | $-217.2M | $10.8M |
营业利润率DNAWASH
| Q1 26 | — | — | ||
| Q4 25 | -211.9% | 34.9% | ||
| Q3 25 | -231.8% | 24.7% | ||
| Q2 25 | -132.1% | 31.6% | ||
| Q1 25 | -184.1% | 26.5% | ||
| Q4 24 | -236.3% | -648.7% | ||
| Q3 24 | -62.0% | 28.5% | ||
| Q2 24 | -396.7% | 28.7% |
净利率DNAWASH
| Q1 26 | — | 21.8% | ||
| Q4 25 | — | 27.0% | ||
| Q3 25 | -207.9% | 19.2% | ||
| Q2 25 | -121.6% | 24.4% | ||
| Q1 25 | -188.2% | 20.6% | ||
| Q4 24 | — | -491.4% | ||
| Q3 24 | -63.3% | 22.6% | ||
| Q2 24 | -386.4% | 22.4% |
每股收益（稀释后）DNAWASH
| Q1 26 | — | $0.66 | ||
| Q4 25 | $-1.41 | $0.84 | ||
| Q3 25 | $-1.45 | $0.56 | ||
| Q2 25 | $-1.10 | $0.68 | ||
| Q1 25 | $-1.68 | $0.63 | ||
| Q4 24 | $-1.91 | $-3.54 | ||
| Q3 24 | $-1.08 | $0.64 | ||
| Q2 24 | $-4.23 | $0.63 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $422.6M | $12.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $508.6M | $546.8M |
| 总资产 | $1.1B | $6.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资DNAWASH
| Q1 26 | — | $12.3M | ||
| Q4 25 | $422.6M | — | ||
| Q3 25 | $495.5M | — | ||
| Q2 25 | $559.4M | — | ||
| Q1 25 | $325.3M | — | ||
| Q4 24 | $561.6M | — | ||
| Q3 24 | $616.2M | — | ||
| Q2 24 | $730.4M | — |
股东权益DNAWASH
| Q1 26 | — | $546.8M | ||
| Q4 25 | $508.6M | $543.6M | ||
| Q3 25 | $559.8M | $533.0M | ||
| Q2 25 | $613.0M | $527.5M | ||
| Q1 25 | $647.4M | $521.7M | ||
| Q4 24 | $716.1M | $499.7M | ||
| Q3 24 | $797.9M | $502.2M | ||
| Q2 24 | $833.1M | $471.0M |
总资产DNAWASH
| Q1 26 | — | $6.5B | ||
| Q4 25 | $1.1B | $6.6B | ||
| Q3 25 | $1.2B | $6.7B | ||
| Q2 25 | $1.2B | $6.7B | ||
| Q1 25 | $1.3B | $6.6B | ||
| Q4 24 | $1.4B | $6.9B | ||
| Q3 24 | $1.5B | $7.1B | ||
| Q2 24 | $1.6B | $7.2B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-47.7M | — |
| 自由现金流经营现金流 - 资本支出 | $-47.7M | — |
| 自由现金流率自由现金流/营收 | -142.8% | — |
| 资本支出强度资本支出/营收 | 0.0% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DNAWASH
| Q1 26 | — | — | ||
| Q4 25 | $-47.7M | $80.3M | ||
| Q3 25 | $-31.6M | $39.6M | ||
| Q2 25 | $-40.3M | $11.3M | ||
| Q1 25 | $-51.5M | $8.4M | ||
| Q4 24 | $-42.4M | $57.7M | ||
| Q3 24 | $-103.5M | $25.7M | ||
| Q2 24 | $-84.4M | $11.2M |
自由现金流DNAWASH
| Q1 26 | — | — | ||
| Q4 25 | $-47.7M | $78.3M | ||
| Q3 25 | — | $39.3M | ||
| Q2 25 | $-40.3M | $10.9M | ||
| Q1 25 | $-59.1M | $8.4M | ||
| Q4 24 | $-56.1M | $53.7M | ||
| Q3 24 | $-118.6M | $24.4M | ||
| Q2 24 | $-111.4M | $9.6M |
自由现金流率DNAWASH
| Q1 26 | — | — | ||
| Q4 25 | -142.8% | 132.2% | ||
| Q3 25 | — | 69.6% | ||
| Q2 25 | -81.2% | 20.2% | ||
| Q1 25 | -122.4% | 14.2% | ||
| Q4 24 | -128.0% | 433.8% | ||
| Q3 24 | -133.2% | 50.4% | ||
| Q2 24 | -198.2% | 19.8% |
资本支出强度DNAWASH
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 3.4% | ||
| Q3 25 | 0.0% | 0.6% | ||
| Q2 25 | 0.1% | 0.7% | ||
| Q1 25 | 15.8% | 0.1% | ||
| Q4 24 | 31.3% | 32.3% | ||
| Q3 24 | 16.9% | 2.6% | ||
| Q2 24 | 48.1% | 3.4% |
现金转化率DNAWASH
| Q1 26 | — | — | ||
| Q4 25 | — | 5.03× | ||
| Q3 25 | — | 3.65× | ||
| Q2 25 | — | 0.86× | ||
| Q1 25 | — | 0.69× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.34× | ||
| Q2 24 | — | 1.03× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DNA
| Cell Engineering Segment | $26.0M | 78% |
| Other | $7.4M | 22% |
WASH
| Net Interest Income | $40.5M | 70% |
| Noninterest Income | $17.3M | 30% |
